- Home
- CLIR vs BOLD Comparison
CLIR vs BOLD Comparison
Compare CLIR & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- BOLD
- Stock Information
- Founded
- CLIR 2008
- BOLD 2018
- Country
- CLIR United States
- BOLD United States
- Employees
- CLIR N/A
- BOLD N/A
- Industry
- CLIR Industrial Machinery/Components
- BOLD
- Sector
- CLIR Industrials
- BOLD
- Exchange
- CLIR Nasdaq
- BOLD Nasdaq
- Market Cap
- CLIR 30.7M
- BOLD 25.5M
- IPO Year
- CLIR 2012
- BOLD 2024
- Fundamental
- Price
- CLIR $0.95
- BOLD $1.30
- Analyst Decision
- CLIR Strong Buy
- BOLD Buy
- Analyst Count
- CLIR 1
- BOLD 4
- Target Price
- CLIR $2.00
- BOLD $4.00
- AVG Volume (30 Days)
- CLIR 2.3M
- BOLD 138.1K
- Earning Date
- CLIR 11-13-2025
- BOLD 11-06-2025
- Dividend Yield
- CLIR N/A
- BOLD N/A
- EPS Growth
- CLIR N/A
- BOLD N/A
- EPS
- CLIR N/A
- BOLD N/A
- Revenue
- CLIR $2,983,000.00
- BOLD N/A
- Revenue This Year
- CLIR $13.13
- BOLD N/A
- Revenue Next Year
- CLIR $143.88
- BOLD N/A
- P/E Ratio
- CLIR N/A
- BOLD N/A
- Revenue Growth
- CLIR 19.03
- BOLD N/A
- 52 Week Low
- CLIR $0.46
- BOLD $1.00
- 52 Week High
- CLIR $1.72
- BOLD $3.75
- Technical
- Relative Strength Index (RSI)
- CLIR 64.15
- BOLD 66.93
- Support Level
- CLIR $0.86
- BOLD $1.10
- Resistance Level
- CLIR $1.12
- BOLD $1.26
- Average True Range (ATR)
- CLIR 0.14
- BOLD 0.04
- MACD
- CLIR 0.02
- BOLD 0.01
- Stochastic Oscillator
- CLIR 68.78
- BOLD 87.50
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.